5.1.Market Drivers42
5.1.1.Demand for therapies that fix damaged tissues and organs rather than just treating symptoms43
5.1.2.Expanding clinical adoption across orthopedics, wound care, cardiology, and reconstructive surgery45
5.1.3.Growing preference for personalized, minimally invasive treatments47
5.2.Market Restraints50
5.3.Market Opportunities54
6.1.Market Share & Positioning58
6.2.Key Strategies by Players61
6.3.Porter Five Forces Analysis64